Evolent Health Inc (EVH)
11.59
+0.28
(+2.48%)
USD |
NYSE |
Nov 21, 16:00
11.58
-0.01
(-0.09%)
Pre-Market: 08:14
Evolent Health Enterprise Value: 1.836B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 1.836B |
| November 20, 2024 | 1.804B |
| November 19, 2024 | 1.878B |
| November 18, 2024 | 1.924B |
| November 15, 2024 | 1.927B |
| November 14, 2024 | 1.960B |
| November 13, 2024 | 1.970B |
| November 12, 2024 | 2.164B |
| November 11, 2024 | 2.243B |
| November 08, 2024 | 2.040B |
| November 07, 2024 | 3.329B |
| November 06, 2024 | 3.352B |
| November 05, 2024 | 3.214B |
| November 04, 2024 | 3.190B |
| November 01, 2024 | 3.202B |
| October 31, 2024 | 3.189B |
| October 30, 2024 | 3.279B |
| October 29, 2024 | 3.179B |
| October 28, 2024 | 3.219B |
| October 25, 2024 | 3.266B |
| October 24, 2024 | 3.122B |
| October 23, 2024 | 3.079B |
| October 22, 2024 | 3.144B |
| October 21, 2024 | 3.170B |
| October 18, 2024 | 3.256B |
| Date | Value |
|---|---|
| October 17, 2024 | 3.374B |
| October 16, 2024 | 3.554B |
| October 15, 2024 | 3.538B |
| October 14, 2024 | 3.623B |
| October 11, 2024 | 3.615B |
| October 10, 2024 | 3.585B |
| October 09, 2024 | 3.524B |
| October 08, 2024 | 3.451B |
| October 07, 2024 | 3.480B |
| October 04, 2024 | 3.533B |
| October 03, 2024 | 3.511B |
| October 02, 2024 | 3.560B |
| October 01, 2024 | 3.614B |
| September 30, 2024 | 3.756B |
| September 27, 2024 | 3.860B |
| September 26, 2024 | 3.818B |
| September 25, 2024 | 3.676B |
| September 24, 2024 | 3.890B |
| September 23, 2024 | 3.938B |
| September 20, 2024 | 4.059B |
| September 19, 2024 | 4.033B |
| September 18, 2024 | 4.037B |
| September 17, 2024 | 4.002B |
| September 16, 2024 | 3.985B |
| September 13, 2024 | 3.953B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
505.93M
Minimum
Mar 16 2020
4.751B
Maximum
May 01 2023
2.590B
Average
2.737B
Median
May 05 2022
Enterprise Value Benchmarks
| Astrana Health Inc | 1.813B |
| American Shared Hospital Services | 34.29M |
| Cryo-Cell International Inc | 75.52M |
| P3 Health Partners Inc | 248.89M |
| Biote Corp | 275.12M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -23.14M |
| Revenue (Quarterly) | 621.40M |
| Total Expenses (Quarterly) | 637.47M |
| EPS Diluted (Quarterly) | -0.27 |
| Gross Profit Margin (Quarterly) | 12.99% |
| Profit Margin (Quarterly) | -3.72% |
| Earnings Yield | -7.85% |
| Normalized Earnings Yield | -5.565 |